Núcleo de Estudos de Doenças Auto-imunes

Sociedade Portuguesa de Medicina Interna
T: (+351) 217 520 570 / Email: info@nedai.org

Artrite Psoriática

Home/Publicações/Artrite Psoriática

Psoriatic arthritis: recent progress in pathophysiology and drug development

2016-10-16T12:02:12+01:00 2013-12-18|Categories: Artrite Psoriática|

Douglas James Veale Abstract Psoriatic arthritis (PsA) is the second most common inflammatory arthropathy, after rheumatoid arthritis diagnosis, in early arthritis clinics. Most patients have established psoriasis, often for years, prior to the onset of joint pain and swelling; in addition, associated features of nail disease, dactylitis, enthesitis, spondylitis or uveitis may be present. Psoriasis may [...]

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis

2016-07-09T09:20:15+01:00 2013-12-18|Categories: Artrite Psoriática|Tags: , , |

Maja Bulatović Ćalasan, Oscar FC van den Bosch1 Marjonne CW Creemers, Martijn Custers, Antonius HM Heurkens, Jan Maarten van Woerkom and Nico M Wulffraat Introduction The aim of this study was to determine the prevalence of gastrointestinal and behavioural symptoms occurring before (anticipatory/associative) and after methotrexate (MTX) administration, termed MTX intolerance, in rheumatoid (RA) and psoriatic arthritis (PsA). Methods Methotrexate Intolerance Severity Score [...]

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

2016-07-09T09:22:29+01:00 2013-9-23|Categories: Artrite Psoriática|

Laura C. Coates, William Tillett, David Chandler, Philip S. Helliwell, Eleanor Korendowych, Stuart Kyle, Iain B. McInnes, Susan Oliver, Anthony Ormerod, Catherine Smith, Deborah Symmons, Nicola Waldron and Neil J. McHugh on behalf of BSR Clinical Affairs Committee & Standards,Audit and Guidelines Working Group and the BHPR Background PsA is a chronic inflammatory arthropathy affecting up to 40% of patients with [...]

Apremilast Eases Psoriatic Arthritis

2016-10-16T12:02:13+01:00 2013-6-13|Categories: Artrite Psoriática|

Published: Jun 13, 2013 | Updated: Jun 14, 2013 By Nancy Walsh, Staff Writer, MedPage Today Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner MADRID -- A year of treatment with apremilast, which targets inflammatory mediators, led to significant long-term reduction in disease activity among [...]

Golimumab, a New Human Tumor Necrosis Factor Antibody, Administered Every Four Weeks as a Subcutaneous Injection in Psoriatic Arthritis

2016-07-09T09:25:07+01:00 2011-10-25|Categories: Artrite Psoriática|

Twenty-Four–Week Efficacy and Safety Results of a Randomized, Placebo-Controlled Study Arthur Kavanaugh, Iain McInnes, Philip Mease, Gerald G. Krueger, Dafna Gladman, Juan Gomez-Reino, Kim Papp, Julie Zrubek, Surekha Mudivarthy, Michael Mack, Sudha Visvanathan, and Anna Beutler Methods. Adult patients with PsA who had at least 3 swollen and 3 tender joints and active psoriasis were randomly assigned to receive subcutaneous injections of placebo (n  113), golimumab 50 mg (n  [...]

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

2016-07-09T09:26:40+01:00 2011-8-4|Categories: Artrite Psoriática|

L Gossec,  J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde,  O FitzGerald, D Aletaha,  P Balint, D Boumpas, J Braun, F C Breedveld, G Burmester, J D Cañete, M de Wit, H Dagfi nrud, K de Vlam, M Dougados, P Helliwell,  A Kavanaugh, T K Kvien, R Landewé, T Luger, M Maccarone, D McGonagle, N McHugh, I B [...]